keyword
https://read.qxmd.com/read/38739933/the-role-of-liquid-liquid-phase-separation-in-the-accumulation-of-pathological-proteins-new-perspectives-on-the-mechanism-of-neurodegenerative-diseases
#1
REVIEW
Xingyu Lu, Jiongtong Lu, Shengnan Li, Sifan Feng, Yan Wang, Lili Cui
It is widely accepted that living organisms form highly dynamic membrane-less organelles (MLOS) with various functions through phase separation, and the indispensable role that phase separation plays in the mechanisms of normal physiological functions and pathogenesis is gradually becoming clearer. Pathological aggregates, regarded as hallmarks of neurodegenerative diseases, have been revealed to be closely related to aberrant phase separation. Specific proteins are assembled into condensates and transform into insoluble inclusions through aberrant phase separation, contributing to the development of diseases...
May 8, 2024: Aging and Disease
https://read.qxmd.com/read/38728199/gut-microbiota-as-a-modifier-of-huntington-s-disease-pathogenesis
#2
REVIEW
Ali Khoshnan
Huntingtin (HTT) protein is expressed in most cell lineages, and the toxicity of mutant HTT in multiple organs may contribute to the neurological and psychiatric symptoms observed in Huntington's disease (HD). The proteostasis and neurotoxicity of mutant HTT are influenced by the intracellular milieu and responses to environmental signals. Recent research has highlighted a prominent role of gut microbiota in brain and immune system development, aging, and the progression of neurological disorders. Several studies suggest that mutant HTT might disrupt the homeostasis of gut microbiota (known as dysbiosis) and impact the pathogenesis of HD...
May 9, 2024: Journal of Huntington's Disease
https://read.qxmd.com/read/38726879/a-programmable-dual-targeting-sirna-scaffold-supports-potent-two-gene-modulation-in-the-central-nervous-system
#3
JOURNAL ARTICLE
Jillian Belgrad, Qi Tang, Sam Hildebrand, Ashley Summers, Ellen Sapp, Dimas Echeverria, Dan O'Reilly, Eric Luu, Brianna Bramato, Sarah Allen, David Cooper, Julia Alterman, Ken Yamada, Neil Aronin, Marian DiFiglia, Anastasia Khvorova
Divalent short-interfering RNA (siRNA) holds promise as a therapeutic approach allowing for the sequence-specific modulation of a target gene within the central nervous system (CNS). However, an siRNA modality capable of simultaneously modulating gene pairs would be invaluable for treating complex neurodegenerative disorders, where more than one pathway contributes to pathogenesis. Currently, the parameters and scaffold considerations for multi-targeting nucleic acid modalities in the CNS are undefined. Here, we propose a framework for designing unimolecular 'dual-targeting' divalent siRNAs capable of co-silencing two genes in the CNS...
May 10, 2024: Nucleic Acids Research
https://read.qxmd.com/read/38705974/a-case-of-hyalinizing-trabecular-tumor-of-the-thyroid-diagnostic-significance-of-pax8-glis3-fusion
#4
JOURNAL ARTICLE
Shuto Hayashi, Nobuyuki Bandoh, Shogo Baba, Misaki Hayashi, Takashi Goto, Miki Takahara, Yasutaka Kato, Eriko Aimono, Hiroshi Nishihara
BACKGROUND: Hyalinizing trabecular tumor (HTT) is an uncommon follicular cell-derived thyroid tumor classified as a low-risk neoplasm by the World Health Organization Classification of Tumors of Endocrine Organs, 5th edition. The PAX8-GLIS3 gene fusion is reportedly a pathognomonic genetic alteration of HTT. CASE PRESENTATION: A 43-year-old Japanese female was incidentally discovered to have an 8-mm, well-defined, hypoechoic mass in the left lobe of the thyroid gland by ultrasound examination...
May 6, 2024: Thyroid Research
https://read.qxmd.com/read/38701619/the-anti-leprosy-drug-clofazimine-reduces-polyq-toxicity-through-activation-of-ppar%C3%AE
#5
JOURNAL ARTICLE
Xuexin Li, Ivó Hernandez, Seda Koyuncu, Balázs Kis, Maria Häggblad, Louise Lidemalm, Anna A Abbas, Sramkó Bendegúz, Anikó Göblös, Lars Brautigam, Jose J Lucas, Jordi Carreras-Puigvert, Daniela Hühn, Karolina Pircs, David Vilchez, Oscar Fernandez-Capetillo
BACKGROUND: PolyQ diseases are autosomal dominant neurodegenerative disorders caused by the expansion of CAG repeats. While of slow progression, these diseases are ultimately fatal and lack effective therapies. METHODS: A high-throughput chemical screen was conducted to identify drugs that lower the toxicity of a protein containing the first exon of Huntington's disease (HD) protein huntingtin (HTT) harbouring 94 glutamines (Htt-Q94 ). Candidate drugs were tested in a wide range of in vitro and in vivo models of polyQ toxicity...
May 2, 2024: EBioMedicine
https://read.qxmd.com/read/38695786/altered-serotonin-1b-receptor-binding-after-escitalopram-for-depression-is-correlated-with-treatment-effect
#6
JOURNAL ARTICLE
M Gärde, G J Matheson, K Varnäs, P Svenningsson, E Hedman-Lagerlöf, J Lundberg, L Farde, M Tiger
BACKGROUND: Major depressive disorder (MDD) is commonly treated with selective serotonin reuptake inhibitors (SSRIs). SSRIs inhibit the serotonin transporter (5-HTT) but the downstream antidepressant mechanism of action of these drugs is poorly understood. The serotonin 1B (5-HT1B) receptor is functionally linked to 5-HTT and 5-HT1B receptor binding and 5-HT1B receptor mRNA is reduced in the raphe nuclei after SSRI-administration in primates and rodents respectively. The effect of SSRI treatment on 5-HT1B receptor binding in MDD subjects has not been examined previously...
May 2, 2024: International Journal of Neuropsychopharmacology
https://read.qxmd.com/read/38695682/let-s-get-fat-emergence-of-s-acylation-as-a-therapeutic-target-in-huntington-disease
#7
JOURNAL ARTICLE
Dale D O Martin, Shaun S Sanders
Protein mislocalization is a key initial step in neurodegeneration, regardless of etiology, and has been linked to changes in the dynamic addition of saturated fatty acids to proteins, a process known as S-acylation. With the advent of new techniques to study S-acylation and the recent discovery of new enzymes that facilitate protein deacylation, novel small molecules are emerging as potential new therapeutic treatments. Huntington disease (HD) is a devastating, fatal neurodegenerative disease characterized by motor, cognitive, and psychiatric deficits caused by a CAG repeat expansion in the HTT gene...
May 2, 2024: Biochemical Society Transactions
https://read.qxmd.com/read/38693252/computing-the-effects-of-temperature-and-osmotic-stress-on-the-seed-germination-of-helianthus-annuus-l-by-using-a-mathematical-model
#8
JOURNAL ARTICLE
Maryam Javid, Sami Ullah, Fazal Amin, Wadood Shah, Tabarak Malik, Mona S Alwahibi, Abdul Waheed, Sezai Ercisli, Baber Ali
An extremely important oil crop in the world, Helianthus annuus L. is one of the world's most significant members of the Asteraceae family. The rate and extent of seed germination and agronomic features are consistently affecting  by temperature (T) and changes in water potential (ψ). A broad hydrothermal time model with T and ψ components could explain sunflower responses over suboptimal T and ψ. A lab experiment was performed using the HTT model to discover both T and ψ and their interactive effects on sunflower germination and also to figure  out the cardinal Ts values...
May 1, 2024: Scientific Reports
https://read.qxmd.com/read/38682050/association-of-5-httlpr-with-post-traumatic-stress-disorder-in-us-service-members
#9
JOURNAL ARTICLE
Xian-Zhang Hu, Robert J Ursano, David Benedek, Xiaoxia Li, Lei Zhang
OBJECTIVE: Post-traumatic stress disorder (PTSD) is a mental disorder that manifests after exposure to a stressful traumatic event, such as combat experience. Accumulated evidence indicates an important genetic influence in the development of PTSD. The serotonin transporter (5-HTT) gene has been identified as a candidate for PTSD and a polymorphism of the serotonin transporter-linked promoter region (5-HTTLPR) is associated with the disorder in the general population. However, whether it is associated with PTSD in active military service members has not been investigated...
2024: Chronic Stress
https://read.qxmd.com/read/38677247/therapeutic-potentials-of-hibiscus-trionum-antioxidant-anti-lipid-peroxidative-hypoglycemic-and-hepatoprotective-effects-in-type-1-diabetic-rats
#10
JOURNAL ARTICLE
Sedef Ziyanok-Demirtas
Recent advances in diabetes treatment have primarily focused on insulin and hypoglycemic agents; however, there is growing interest in exploring herbal and synthetic alternatives. Numerous studies have highlighted the preventive effectiveness of regular plant consumption in managing chronic conditions, particularly diabetes. Hibiscus, a medicinal plant recognized in various cultures, is known for its diverse health benefits. This study investigated the impact of Hibiscus trionum on glycemic control and assessed its influence on glucose and insulin levels in diabetes-induced rats...
April 26, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38672067/molecular-pathology-of-thyroid-tumors-essential-points-to-comprehend-regarding-the-latest-who-classification
#11
REVIEW
Tomohiro Chiba
In 2022, the new WHO Classification of Endocrine and Neuroendocrine Tumors, Fifth Edition (beta version) (WHO 5th), was published. Large-scale genomic analyses such as The Cancer Genome Atlas (TCGA) have revealed the importance of understanding the molecular genetics of thyroid tumors. Consequently, the WHO 5th was fundamentally revised, resulting in a systematic classification based on the cell of origin of tumors and their clinical risk. This paper outlines the following critical points of the WHO 5th. 1...
March 22, 2024: Biomedicines
https://read.qxmd.com/read/38667528/aggressiveness-in-italian-children-with-adhd-maoa-gene-polymorphism-involvement
#12
JOURNAL ARTICLE
Ludovico Neri, Beatrice Marziani, Pierluigi Sebastiani, Tiziana Del Beato, Alessia Colanardi, Maria Pia Legge, Anna Aureli
ADHD is a neurodevelopmental disorder that children and adults can develop. A complex interplay of genetic and environmental factors may underlie interindividual variability in ADHD and potentially related aggressive behavior. Using high-resolution molecular biology techniques, we investigated the impact of some MAOA and SLC6A4 variations on ADHD and aggressive behavior in a group of 80 Italian children with ADHD and in 80 healthy controls. We found that homozygous genotypes of MAOA rs6323 and rs1137070 were associated with an increased risk of ADHD ( p = 0...
March 31, 2024: Diseases (Basel)
https://read.qxmd.com/read/38667408/high-trunk-truncation-as-a-potential-sustainable-management-option-for-asian-longhorned-beetle-on-salix-babylonica
#13
JOURNAL ARTICLE
Chen Huang, Hualing Wang, Xiaoxia Hai, Zhigang Wang, Fei Lyu
The Asian longhorned beetle (ALB) causes substantial economic and ecological losses, thus, an environmentally friendly management strategy is needed. Here, we propose high trunk truncation (HTT), the removal of the above 200 cm portion of trees, as a sustainable management strategy to control ALB. To examine the hypothesis, an initial step involved the assessment of various biological characteristics of ALB. Subsequently, a controlled field experiment was carried out utilizing HTT. Finally, HTT was applied in two additional ALB infestation regions...
April 16, 2024: Insects
https://read.qxmd.com/read/38666850/role-of-tfeb-in-huntington-s-disease
#14
REVIEW
Javier Ojalvo-Pacheco, Sokhna M S Yakhine-Diop, José M Fuentes, Marta Paredes-Barquero, Mireia Niso-Santano
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by an expansion of the CAG trinucleotide repeat in exon 1 of the huntingtin (HTT) gene. This expansion leads to a polyglutamine (polyQ) tract at the N-terminal end of HTT, which reduces the solubility of the protein and promotes its accumulation. Inefficient clearance of mutant HTT (mHTT) by the proteasome or autophagy-lysosomal system leads to accumulation of oligomers and toxic protein aggregates in neurons, resulting in impaired proteolytic systems, transcriptional dysregulation, impaired axonal transport, mitochondrial dysfunction and cellular energy imbalance...
April 4, 2024: Biology
https://read.qxmd.com/read/38660915/copper-enhances-aggregational-toxicity-of-mutant-huntingtin-in-a-drosophila-model-of-huntington-s-disease
#15
JOURNAL ARTICLE
Amanda G Lobato, Natalie Ortiz-Vega, Yi Zhu, Deepa Neupane, Katlyn K Meier, R Grace Zhai
Huntington's disease (HD) is a progressive neurodegenerative disorder with clinical presentations of moderate to severe cognitive, motor, and psychiatric disturbances. HD is caused by the trinucleotide repeat expansion of CAG of the huntingtin (HTT) gene. The mutant HTT protein containing pathological polyglutamine (polyQ) extension is prone to misfolding and aggregation in the brain. It has previously been observed that copper and iron concentrations are increased in the striata of post-mortem human HD brains...
January 2024: Biochimica et Biophysica Acta. Molecular Basis of Disease
https://read.qxmd.com/read/38653938/neuroinflammation-and-the-role-of-epigenetic-based-therapies-for-huntington-s-disease-management-the-new-paradigm
#16
REVIEW
Pooja Temgire, Richmond Arthur, Puneet Kumar
Huntington's disease (HD) is an inherited, autosomal, neurodegenerative ailment that affects the striatum of the brain. Despite its debilitating effect on its patients, there is no proven cure for HD management as of yet. Neuroinflammation, excitotoxicity, and environmental factors have been reported to influence the regulation of gene expression by modifying epigenetic mechanisms. Aside focusing on the etiology, changes in epigenetic mechanisms have become a crucial factor influencing the interaction between HTT protein and epigenetically transcribed genes involved in neuroinflammation and HD...
April 23, 2024: Inflammopharmacology
https://read.qxmd.com/read/38640164/insulin-degrading-enzyme-efficiently-degrades-polyq-peptides-but-not-expanded-polyq-huntingtin-fragments
#17
JOURNAL ARTICLE
Karlijne W Geijtenbeek, Angela Santiago Aranda, Alicia Sanz Sanz, Jolien Janzen, Aleksandra E Bury, Suzan Kors, Nur Al Amery, Nina C M Schmitz, Eric A J Reits, Sabine Schipper-Krom
BACKGROUND: Huntington's disease is an inheritable autosomal dominant disorder caused by an expanded CAG trinucleotide repeat within the Huntingtin gene, leading to a polyglutamine (polyQ) expansion in the mutant protein. OBJECTIVE: A potential therapeutic approach for delaying or preventing the onset of the disease involves enhancing the degradation of the aggregation-prone polyQ-expanded N-terminal mutant huntingtin (mHTT) exon1 fragment. A few proteases and peptidases have been identified that are able to cleave polyQ fragments with low efficiency...
April 16, 2024: Journal of Huntington's Disease
https://read.qxmd.com/read/38639203/detection-of-and-response-to-gender-based-violence-a-quality-improvement-project-across-three-secondary-mental-health-services-in-london
#18
JOURNAL ARTICLE
Roxanne C Keynejad, Theo Boardman-Pretty, Sarah Barber, John Tweed, Emily Forshall, Alice Edwards, Joshua Shotton, Claire A Wilson
AIMS AND METHOD: Our team of core and higher psychiatry trainees aimed to improve secondary mental health service detection of and response to gender-based violence (GBV) in South East London. We audited home treatment team (HTT), drug and alcohol (D&A) service and in-patient ward clinical records ( n = 90) for female and non-binary patients. We implemented brief, cost-neutral staff engagement and education interventions at service, borough and trust levels before re-auditing ( n = 86), completing a plan-do-study-act cycle...
April 19, 2024: BJPsych Bulletin
https://read.qxmd.com/read/38612657/huntington-s-disease-complex-pathogenesis-and-therapeutic-strategies
#19
REVIEW
Huichun Tong, Tianqi Yang, Shuying Xu, Xinhui Li, Li Liu, Gongke Zhou, Sitong Yang, Shurui Yin, Xiao-Jiang Li, Shihua Li
Huntington's disease (HD) arises from the abnormal expansion of CAG repeats in the huntingtin gene ( HTT ), resulting in the production of the mutant huntingtin protein (mHTT) with a polyglutamine stretch in its N-terminus. The pathogenic mechanisms underlying HD are complex and not yet fully elucidated. However, mHTT forms aggregates and accumulates abnormally in neuronal nuclei and processes, leading to disruptions in multiple cellular functions. Although there is currently no effective curative treatment for HD, significant progress has been made in developing various therapeutic strategies to treat HD...
March 29, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38609352/splice-modulators-target-pms1-to-reduce-somatic-expansion-of-the-huntington-s-disease-associated-cag-repeat
#20
JOURNAL ARTICLE
Zachariah L McLean, Dadi Gao, Kevin Correia, Jennie C L Roy, Shota Shibata, Iris N Farnum, Zoe Valdepenas-Mellor, Marina Kovalenko, Manasa Rapuru, Elisabetta Morini, Jayla Ruliera, Tammy Gillis, Diane Lucente, Benjamin P Kleinstiver, Jong-Min Lee, Marcy E MacDonald, Vanessa C Wheeler, Ricardo Mouro Pinto, James F Gusella
Huntington's disease (HD) is a dominant neurological disorder caused by an expanded HTT exon 1 CAG repeat that lengthens huntingtin's polyglutamine tract. Lowering mutant huntingtin has been proposed for treating HD, but genetic modifiers implicate somatic CAG repeat expansion as the driver of onset. We find that branaplam and risdiplam, small molecule splice modulators that lower huntingtin by promoting HTT pseudoexon inclusion, also decrease expansion of an unstable HTT exon 1 CAG repeat in an engineered cell model...
April 12, 2024: Nature Communications
keyword
keyword
70418
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.